Neurological Aspects of Substance Use Disorder: An Introduction.

Semin Neurol

Division of Neurology Education, Department of Neurology, Mayo Clinic, Rochester, Minnesota.

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0044-1787551DOI Listing

Publication Analysis

Top Keywords

neurological aspects
4
aspects substance
4
substance disorder
4
disorder introduction
4
neurological
1
substance
1
disorder
1
introduction
1

Similar Publications

In recent years, it has been increasingly recognized that tumor growth relies not only on support from the surrounding microenvironment but also on the tumors capacity to adapt to - and actively manipulate - its niche. While targeting angiogenesis and modulating the local immune environment have been explored as therapeutic approaches, these strategies have yet to yield effective treatments for brain tumors and remain under refinement. More recently, the nervous system itself has been explored as a critical environmental support for cancer, with extensive neuro-tumoral interactions observed both intracranially and in extracranial sites containing neural components.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Barrow Neurological Institute, Phoenix, AZ, USA; Arizona State University, Tempe, AZ, USA.

Background: TDP-43 is an RNA binding protein that is a pathological hallmark of multiple neurodegenerative diseases including Amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer's disease (AD). The frequency of observed TDP-43 pathology is estimated at 97% in ALS, 45% in FTD and 40-57% in AD and is characterized by a mislocalization of TDP-43 from the nucleus to the cytoplasm. Indeed, TDP-43 is the third most common proteinopathy in AD, behind only Amyloid beta and Tau.

View Article and Find Full Text PDF

Background: ApoE4 is the strongest genetic risk factor for late onset Alzheimer's Disease (AD). However, ApoE4 has also been suggested to exhibit antagonistic pleiotropy, a phenomenon by which some allelic variations of a gene promote fitness during certain periods of life but may be detrimental in others. Previous work suggests that ApoE4 carriers exhibit superior performance on executive function tasks in early and middle age, while later in life (>70 years) ApoE4 carriers experience greater cognitive decline across multiple domains.

View Article and Find Full Text PDF

Background: Intracellular accumulation of tau tangles in the brain is one of the most prominent manifestations of Alzheimer's disease (AD). Progression thereof across the AD stages has specific temporal and spatial patterns, wherein time is informative of space and vice versa. Here we introduce a novel method, Manifold Component Analysis (MCA), to represent tangle accumulation in 2D, reflecting the spatial aspect of tau propagation stages to further relate it to the temporal aspect thereof.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

CBI en Demencias y Enfermedades Desmielinizantes del Sistema Nervioso, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.

Background: Early-onset Alzheimer's disease (EOAD) is a rare and devasting form of Alzheimer disease that represents 5-10% of the total number of Alzheimer disease (AD). It is significantly less well studied than the late-onset form of AD. The clinical presentation is heterogeneous, the amnestic variant is the most frequent (75%).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!